World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
79
Citations
19186
World Ranking
17728
National Ranking
8

Overview

David C. Kaslow is affiliated with the Food and Drug Administration in Thailand. Their research primarily falls within the field of Medicine, with a detailed focus on Infectious Diseases, Health, Public Health, Environmental and Occupational Health, Epidemiology, and Endocrinology.

The scientist has contributed extensively to topics including Vaccine Coverage and Hesitancy, SARS-CoV-2 and COVID-19 Research, Viral gastroenteritis research and epidemiology, Streptococcal Infections and Treatments, Antimicrobial Resistance in Staphylococcus, Viral Infections and Outbreaks Research, and Vibrio bacteria research studies.

David C. Kaslow has published in various scientific venues, with frequent contributions to:

  • npj Vaccines
  • Open Forum Infectious Diseases
  • Vaccine
  • EClinicalMedicine
  • The Lancet Global Health

Notable recent papers include:

  • "Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review," 2022, The Lancet Global Health
  • "Global public health security and justice for vaccines and therapeutics in the COVID-19 pandemic," 2021, EClinicalMedicine
  • "Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review," 2022, PubMed
  • "The silent and dangerous inequity around access to COVID-19 testing: A call to action," 2021, EClinicalMedicine
  • "KSHV (HHV8) vaccine: promises and potential pitfalls for a new anti-cancer vaccine," 2022, npj Vaccines

David C. Kaslow has collaborated frequently with the following co-authors:

  • Annelies Wilder-Smith (13 joint publications)
  • Gagandeep Kang (10 joint publications)
  • Peter J. Hotez (9 joint publications)
  • Carolina Batista (9 joint publications)
  • Önder Ergönül (9 joint publications)

Best Publications

  • Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity.

    John W. Shiver;Tong-Ming Fu;Ling Chen;Danilo R. Casimiro

  • Seven-Year Efficacy of RTS,S/AS01 Malaria Vaccine among Young African Children

    Ally Olotu;Gregory Fegan;Juliana Wambua;George Nyangweso

  • A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains.

    David C. Kaslow;Isabella A. Quakyi;Chiang Syin;Michael G. Raum

  • Clinical Immunity to Plasmodium falciparum Malaria Is Associated with Serum Antibodies to the 19-kDa C-Terminal Fragment of the Merozoite Surface Antigen, PfMSP-l

    Andréa F. Egan;Joanne Morris;Guy Barnish;Stephen Allen

  • Phase I/IIa Safety, Immunogenicity, and Efficacy Trial of NYVAC-Pf7, a Pox-Vectored, Multiantigen, Multistage Vaccine Candidate for Plasmodium falciparum Malaria

    Christian F. Ockenhouse;Pei Fang Sun;David E. Lanar;Bruce T. Wellde

  • Shotgun DNA microarrays and stage-specific gene expression in Plasmodium falciparum malaria.

    Rhian E. Hayward;Joseph L. DeRisi;Suad Alfadhli;David C. Kaslow

  • A longitudinal investigation of IgG and IgM antibody responses to the merozoite surface protein-1 19-kiloDalton domain of Plasmodium falciparum in pregnant women and infants: associations with febrile illness, parasitemia, and anemia.

    Oralee H. Branch;Venkatachalam Udhayakumar;Allen W. Hightower;Aggrey J. Oloo

  • Effects of magainins and cecropins on the sporogonic development of malaria parasites in mosquitoes.

    R. W. Gwadz;D. Kaslow;Jong-Youn Lee;W. L. Maloy

  • Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys.

    Sanjai Kumar;Anjali Yadava;David B. Keister;Jing Hui Tian

  • malERA: An updated research agenda for malaria elimination and eradication.

    Regina N. Rabinovich;Regina N. Rabinovich;Chris Drakeley;Abdoulaye A. Djimde;B. Fenton Hall

  • A DNA prime-modified vaccinia virus ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challenge.

    S. J. Dunachie;M. Walther;J. E. Epstein;S. Keating

  • Fractional Third and Fourth Dose of RTS,S/AS01 Malaria Candidate Vaccine: A Phase 2a Controlled Human Malaria Parasite Infection and Immunogenicity Study

    Jason A. Regules;Susan B. Cicatelli;Jason W. Bennett;Kristopher M. Paolino

  • PATHWAYS AND STRATEGIES FOR DEVELOPING A MALARIA BLOOD-STAGE VACCINE*

    Michael F. Good;David C. Kaslow;Louis H. Miller

  • Serum antibodies from malaria-exposed people recognize conserved epitopes formed by the two epidermal growth factor motifs of MSP1(19), the carboxy-terminal fragment of the major merozoite surface protein of Plasmodium falciparum.

    A F Egan;J A Chappel;P A Burghaus;J S Morris

  • NYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria.

    J. A. Tine;D. E. Lanar;D. M. Smith;B. T. Wellde

  • WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23-24 March 2015.

    Kayvon Modjarrad;Birgitte Giersing;David C Kaslow;Peter G Smith

  • Cloning of the Plasmodium vivax Duffy receptor

    Xiangdong Fang;David C. Kaslow;John H. Adams;Louis H. Miller

  • Efficacy of Two Alternate Vaccines Based on Plasmodium falciparum Merozoite Surface Protein 1 in an Aotus Challenge Trial

    Anthony W. Stowers;Vittoria Cioce;Richard L. Shimp;Mark Lawson

  • Natural immune response to the C-terminal 19-kilodalton domain of Plasmodium falciparum merozoite surface protein 1.

    Ya Ping Shi;Umar Sayed;Shoukat H. Qari;Jacquelin M. Roberts

  • The Path to Group A Streptococcus Vaccines: World Health Organization Research and Development Technology Roadmap and Preferred Product Characteristics

    Johan Vekemans;Fernando Gouvea-Reis;Jerome H Kim;Jean-Louis Excler

Frequent Co-Authors

Annelies Wilder-Smith
Annelies Wilder-Smith University of Bern
Peter Smith
Peter Smith University of Aberdeen
Sarah C. Gilbert
Sarah C. Gilbert University of Oxford
Heidi J Larson
Heidi J Larson London School of Hygiene & Tropical Medicine
Maria Elena Bottazzi
Maria Elena Bottazzi Baylor College of Medicine
Timothy P. Sheahan
Timothy P. Sheahan University of North Carolina at Chapel Hill
Peter J. Hotez
Peter J. Hotez Baylor College of Medicine
Philip Bejon
Philip Bejon University of Oxford
Shabir A. Madhi
Shabir A. Madhi University of the Witwatersrand
Ruth A. Karron
Ruth A. Karron Johns Hopkins University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're interested in medicine but want to explore alternative career pathways, several accredited online degrees can help launch or advance your career in healthcare. Many schools now offer flexible, online coursework tailored to busy professionals seeking to expand their impact.

Nursing remains a popular route, with programs such as rn to np programs allowing registered nurses to advance to nurse practitioner roles entirely online. Those with an associate’s degree can also consider rn to bsn online no clinicals accredited programs, which eliminate in-person clinicals for additional convenience.

For those drawn to preventive care and public health, nutrition science has become more accessible. Explore your options with the best online nutrition degree programs, ideal for students interested in wellness and dietary health.

Leadership-minded individuals might be interested in healthcare administration. Consider enrolling in one of the top cahme accredited mha programs to pursue management roles in hospitals or health systems.

Best Scientists Citing David C. Kaslow

Trending Scientists

Recently Published Articles